CSTL News
Late-Breaking EADV 2026 Data Support Use of DecisionDx-Melanoma in SLNB Decision-Making and Risk-Aligned Post Surgical Management
Late-Breaking EADV 2026 Data Support Use of DecisionDx-Melanoma in SLNB Decision-Making and Risk-Aligned Post Surgical Management Late-Breaking EADV 2026 Data Support Use of DecisionDx-Melanoma in SLNB Decision-Making and Risk-Aligned Post Surgical ManagementPR NewswireFRIENDSWOOD, Texas, Sept. 30...
PR Newswire
Late-Breaking EADV 2026 Data Support Use of DecisionDx-Melanoma in SLNB Decision-Making and Risk-Aligned Post Surgical Management
Late-Breaking EADV 2026 Data Support Use of DecisionDx-Melanoma in SLNB Decision-Making and Risk-Aligned Post Surgical Management Late-Breaking EADV 2026 Data Support Use of DecisionDx-Melanoma in SLNB Decision-Making and Risk-Aligned Post Surgical ManagementPR NewswireFRIENDSWOOD, Texas, Sept. 30...
PR Newswire
New Study Shows That TissueCypher Changed Management at an Expert Surgery Center in 90% of Patients With Non-Dysplastic Barrett's Esophagus
New Study Shows That TissueCypher Changed Management at an Expert Surgery Center in 90% of Patients With Non-Dysplastic Barrett's Esophagus New Study Shows That TissueCypher Changed Management at an Expert Surgery Center in 90% of Patients With Non-Dysplastic Barrett's EsophagusPR...
PR Newswire
Castle Biosciences to Open New Laboratory Facility in Scottsdale
Castle Biosciences to Open New Laboratory Facility in Scottsdale Castle Biosciences to Open New Laboratory Facility in ScottsdalePR NewswireFRIENDSWOOD, Texas, Sept. 22, 2026 New 55,000-square-foot facility expands Castle's operational footprint in Arizona to support growing test volumes and...
PR Newswire
New Decision Modeling Study Demonstrates TissueCypher Significantly Improves Risk-Aligned Management for Patients with Barrett's Esophagus
New Decision Modeling Study Demonstrates TissueCypher Significantly Improves Risk-Aligned Management for Patients with Barrett's Esophagus New Decision Modeling Study Demonstrates TissueCypher Significantly Improves Risk-Aligned Management for Patients with Barrett's EsophagusPR...
PR Newswire
JAAD Publication Shows Improved Performance of DecisionDx-SCC
JAAD Publication Shows Improved Performance of DecisionDx-SCC JAAD Publication Shows Improved Performance of DecisionDx-SCC PR Newswire FRIENDSWOOD, Texas, Sept. 9, 2026 DecisionDx-SCC shows enhanced performance with the integration of select clinicopathologic risk factors, providing a more precise...
PR Newswire
SciBase receives additional order from Castle Biosciences, advancing the collaboration
SciBase receives additional order from Castle Biosciences, advancing the collaboration SciBase receives additional order from Castle Biosciences, advancing the collaboration PR Newswire STOCKHOLM, Sept. 8, 2026 STOCKHOLM, Sept. 8, 2026 /PRNewswire/ -- SciBase Holding AB("SciBase") (STO: SCIB), a...
PR Newswire
Castle Biosciences, Inc. (CSTL) Is Up 15.46% in One Week: What You Should Know
Does Castle Biosciences, Inc. (CSTL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks
Does Castle Biosciences (CSTL) Have the Potential to Rally 31.46% as Wall Street Analysts Expect?
The consensus price target hints at a 31.5% upside potential for Castle Biosciences (CSTL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks
Castle Biosciences to Participate in Upcoming Investor Conferences
Castle Biosciences to Participate in Upcoming Investor Conferences Castle Biosciences to Participate in Upcoming Investor Conferences PR Newswire FRIENDSWOOD, Texas, Aug. 20, 2026 FRIENDSWOOD, Texas, Aug. 20, 2026 /PRNewswire/ -- Castle Biosciences, Inc.(Nasdaq: CSTL), a company improving health...
PR Newswire
Castle Biosciences Approved for Dual Listing on Nasdaq Texas
Castle Biosciences Approved for Dual Listing on Nasdaq Texas Castle Biosciences Approved for Dual Listing on Nasdaq Texas PR Newswire FRIENDSWOOD, Texas, Aug. 17, 2026 FRIENDSWOOD, Texas, Aug. 17, 2026 /PRNewswire/ -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through...
PR Newswire